Addressing challenges faced for optimal bi-specific and Immunocytokines engineering
18 Nov 2024
Formats & Scaffolds
- Optimal rationale design for CIS versus TRANS-potency (target selection, novel masking strategies)
- Adequate Antibody engineering for dual binding and potency (linker, Fc domain, structural complexity, epitope)
- How to use AI in the design of bispecific antibody
